APA

Scholtz A. W., Hahn A., Stefflova B., Medzhidieva D., Ryazantsev S. V., Paschinin A., Kunelskaya N., Schumacher K. & Weisshaar G. (20200127). Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial. : Clinical drug investigation.

Chicago

Scholtz Arne W, Hahn Ales, Stefflova Bohdana, Medzhidieva Daniela, Ryazantsev Sergey V, Paschinin Alexander, Kunelskaya Natalia, Schumacher Kai and Weisshaar Gerhard. 20200127. Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial. : Clinical drug investigation.

Harvard

Scholtz A. W., Hahn A., Stefflova B., Medzhidieva D., Ryazantsev S. V., Paschinin A., Kunelskaya N., Schumacher K. and Weisshaar G. (20200127). Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial. : Clinical drug investigation.

MLA

Scholtz Arne W, Hahn Ales, Stefflova Bohdana, Medzhidieva Daniela, Ryazantsev Sergey V, Paschinin Alexander, Kunelskaya Natalia, Schumacher Kai and Weisshaar Gerhard. Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial. : Clinical drug investigation. 20200127.